Sophie Adams

Sophie Adams is a skilled medical writer currently employed at Oxford PharmaGenesis since July 2022, where previous roles included Associate Medical Writer. Prior to this, Sophie served as a Postdoctoral Researcher at Queen Mary University of London from October 2020 to December 2021, and as a PhD Student Researcher at Barts Cancer Institute from October 2015 to November 2019, focusing on centrosome amplification and its effects on the pancreatic tumour microenvironment. Sophie’s early experience includes a work placement at Merck Millipore in 2012, contributing to various research and development projects. Academically, Sophie holds a Doctorate in Molecular Oncology from Queen Mary University of London, a Master's in Cancer Biology from the University of Dundee, and a Bachelor's degree in Cell/Cellular and Molecular Biology from the University of St Andrews.